PVI
EW icon

Pura Vida Investments’s Edwards Lifesciences EW Stock Holding History

Pura Vida Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-105,000
Closed -$3.83M – 80
2017
Q3 		$3.83M Buy
105,000
+15,000
+17% +$572K 1.12% 36
2017
Q2 		$3.55M Buy
+90,000
New +$3.29M 1.41% 29
2016
Q1 		– Sell
-150,000
Closed -$3.95M – 89
2015
Q4 		$3.95M Buy
+150,000
New +$3.9M 1.67% 26

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pura Vida Investments's EW Position: Q2 2024 in Review

Pura Vida Investments sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 15,408 shares — an estimated $1.47M sold.

Pura Vida Investments first reported a position in EW in Q4 2014 and held it in 7 quarters. The position peaked at $9.55M in Q4 2014. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Pura Vida Investments reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Pura Vida Investments sold 15,408 Edwards Lifesciences shares in Q2 2024, an estimated $1.47M.
  • Pura Vida Investments first reported a position in Edwards Lifesciences in Q4 2014 and held it in 7 quarters.
  • Pura Vida Investments's Edwards Lifesciences position peaked at $9.55M in Q4 2014.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.